References
[1] Liaw YF, Chu CM. Hepatitis B virus infection[J]. Lancet, 2009, 373(9663):582-592.
[2] Komatsu H, Inui A. Hepatitis B virus infection in children[J]. Expert Rev Anti Infect Ther, 2015, 13(4):427-450.
[3] Zeng Z. Human genes involved in hepatitis B virus infection[J]. World J Gastroenterol, 2014, 20(24):7696-7706.
[4] 周琴, 郜玉峰, 赵小苗, 等. IL-4基因多态性与HBV遗传易感性的研究[J]. 中华疾病控制杂志, 2014, 18(10):968-971.
[5] Motavaf M, Safari S, Alavian SM. Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection:a review study[J]. Hepat Mon, 2014, 14(7):e19879.
[6] Wu L, Chen L, Zhou L, et al. Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population[J]. Hepat Mon, 2011, 11(6):469-474.
[7] 费筠, 陈月, 吴文苑. 白细胞介素与HBV感染的关系[J]. 临床肝胆病杂志, 2014, 30(2):174-177.
[8] 夏旭, 杨钦河. 白细胞介素-19的研究近况[J]. 国外医学(免疫学分册), 2002, 25(6):324-328.
[9] Liao YC, Liang WG, Chen FW, et al. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha[J]. J Immunol, 2002, 169(8):4288-4297.
[10] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南[J]. 中华传染病杂志, 2005, 23(6):421-431.
[11] Zhang PA, Wu JM, Li Y, et al. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population[J]. World J Gastroenterol, 2005, 11(11):1594-1598.
[12] Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus[J]. Am J Gastroenterol, 2002, 97(8):2086-2092.
[13] Shin HD, Park BL, Kim LH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma[J]. Hum Mol Genet, 2003, 12(8):901-906.
[14] Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection[J]. Chin Med J (Engl), 2005, 118(19):1604-1609.
[15] Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, et al. Association between IL-10 gene promoter polymorphisms (-592 A/C,-819 T/C,-1082 A/G) and susceptibility to HBV infection in an Iranian population[J]. Hepat Mon, 2016, 16(2):e32427.
[16] Truelove AL, Oleksyk TK, Shrestha S, et al. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome[J]. Int J Immunogenet, 2008, 35(3):255-264.
[17] Ryckman KK, Fielding K, Hill AV, et al. Host genetic factors and vaccine-induced immunity to HBV infection:haplotype analysis[J]. PLoS One, 2010, 5(8):e12273.
[18] Yamamoto-Furusho JK, Álvarez-León E, Fragoso JM, et al. Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis[J]. Hum Immunol, 2011, 72(11):1029-1032.
[19] Shao ZJ, Zhang L, Xu JQ, et al. Mother-to-infant transmission of hepatitis B virus:a Chinese experience[J]. J Med Virol, 2011, 83(5):791-795.
[20] Yucesoy B, Talzhanov Y, Johnson VJ, et al. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations[J]. Vaccine, 2013, 31(46):5381-5391.